Your browser doesn't support javascript.
loading
Human Mitochondrial Ribosomal RNA Modification-Based Classification Contributes to Discriminate the Prognosis and Immunotherapy Response of Glioma Patients.
Wang, Peng; Li, Jingying; Wu, Miaojing; Ye, Minghua; Huang, Kai; Zhu, Xingen.
Afiliación
  • Wang P; Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Li J; Institute of Neuroscience, Nanchang University, Nanchang, China.
  • Wu M; Comprehensive Intensive Care Unit, Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Ye M; Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Huang K; Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhu X; Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Front Immunol ; 12: 722479, 2021.
Article en En | MEDLINE | ID: mdl-34566979

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Ribosómico / Procesamiento Postranscripcional del ARN / Glioma / Mitocondrias Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Ribosómico / Procesamiento Postranscripcional del ARN / Glioma / Mitocondrias Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza